21 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26004580	5	An unprecedented dual antagonist and agonist of human Transglutaminase 2.	Stanford University
26005023	25	(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.	University of Leeds
24432384	7	Tissue transglutaminase: an emerging target for therapy and imaging.	TBA
23835447	32	Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.	Aston University
22224594	346	Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.	Evotec (Uk)
24900424	60	SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.	TBA
24900540	47	Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.	TBA
21215619	114	Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.	Stanford University
17948018	17	Mechanisms, biology and inhibitors of deubiquitinating enzymes.	Institute For Bio-Medical Research
17590341	3	Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.	Stanford University
17149878	15	Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.	Stanford University
15780627	61	Structure-activity relationship study of novel tissue transglutaminase inhibitors.	Harvard Medical School
29664627	46	N	Helmholtz-Zentrum Dresden-Rossendorf
28810189	11	Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.	Alma Mater Studiorum-University of Bologna
28122456	4	Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.	Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
28858494	30	Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.	University of Ottawa
18804034	9	Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.	Duke University Medical Center